Anti-TGO1/ MIA3/ ARNT functional antibody

Anti-TGO1/ MIA3/ ARNT functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to MIA3/MIA3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0348-Ab-1/ GM-Tg-hg-SE0348-Ab-2Anti-Human MIA3 monoclonal antibodyHuman
GM-Tg-rg-SE0348-Ab-1/ GM-Tg-rg-SE0348-Ab-2Anti-Rat MIA3 monoclonal antibodyRat
GM-Tg-mg-SE0348-Ab-1/ GM-Tg-mg-SE0348-Ab-2Anti-Mouse MIA3 monoclonal antibodyMouse
GM-Tg-cynog-SE0348-Ab-1/ GM-Tg-cynog-SE0348-Ab-2Anti-Cynomolgus/ Rhesus macaque MIA3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0348-Ab-1/ GM-Tg-felg-SE0348-Ab-2Anti-Feline MIA3 monoclonal antibodyFeline
GM-Tg-cang-SE0348-Ab-1/ GM-Tg-cang-SE0348-Ab-2Anti-Canine MIA3 monoclonal antibodyCanine
GM-Tg-bovg-SE0348-Ab-1/ GM-Tg-bovg-SE0348-Ab-2Anti-Bovine MIA3 monoclonal antibodyBovine
GM-Tg-equg-SE0348-Ab-1/ GM-Tg-equg-SE0348-Ab-2Anti-Equine MIA3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0348-Ab-1/ GM-Tg-hg-SE0348-Ab-2; GM-Tg-rg-SE0348-Ab-1/ GM-Tg-rg-SE0348-Ab-2;
GM-Tg-mg-SE0348-Ab-1/ GM-Tg-mg-SE0348-Ab-2; GM-Tg-cynog-SE0348-Ab-1/ GM-Tg-cynog-SE0348-Ab-2;
GM-Tg-felg-SE0348-Ab-1/ GM-Tg-felg-SE0348-Ab-2; GM-Tg-cang-SE0348-Ab-1/ GM-Tg-cang-SE0348-Ab-2;
GM-Tg-bovg-SE0348-Ab-1/ GM-Tg-bovg-SE0348-Ab-2; GM-Tg-equg-SE0348-Ab-1/ GM-Tg-equg-SE0348-Ab-2
Products NameAnti-MIA3 monoclonal antibody
Formatmab
Target NameMIA3
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-MIA3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0348-Ag-1Recombinant multi-species TGO1/ MIA3/ ARNT protein
    ORF Viral VectorpGMAD000114human MIA3 Adenovirus plasmid
    ORF Viral VectorvGMAD000114human MIA3 Adenovirus particle


    Target information

    Target IDGM-SE0348
    Target NameMIA3
    Gene ID375056,338366,683007,704405,100855882,101097539,509133
    Gene Symbol and Synonyms9130229H14Rik,A930039G15Rik,ARNT,B230399H06Rik,D320,Gm1525,MIA3,ODCD2,TANGO,TANGO1,UNQ6077
    Uniprot AccessionQ5JRA6,Q0VC16
    Uniprot Entry NameTGO1_HUMAN,TGO1_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000154305
    Target ClassificationN/A

    The target: MIA3, gene name: MIA3, also named as ARNT, D320, TANGO, TANGO1, UNQ6077. Enables cargo receptor activity. Involved in several processes, including COPII-coated vesicle cargo loading; cell migration involved in sprouting angiogenesis; and regulation of leukocyte migration. Located in endoplasmic reticulum exit site and endoplasmic reticulum membrane. Is integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.